Saxenda 0.6mg Injection Pen

Description

Saxenda 0.6mg injection pen is the initial dose of liraglutide-based GLP-1 therapy used for weight management in adults with obesity or overweight conditions. It works by mimicking the GLP-1 hormone, helping reduce hunger, control calorie intake, and support steady fat loss.

This 0.6mg starting dose allows your body to adjust to the medication before increasing to higher doses such as 1.2mg, 1.8mg, 2.4mg, and 3.0mg.

Key Features:

• Contains 0.6mg liraglutide per injection

• Once-daily prefilled pen for precise self-administration

• Designed as the starting dose in the Saxenda treatment plan

• Clinically proven to reduce appetite and promote weight loss (FDA Guide)

• Suitable for use under medical supervision

How To Administer Saxenda:

• Inject once daily, at any time of the day, with or without food

• Administer subcutaneously in the abdomen, thigh, or upper arm

• Continue at 0.6mg for one week, then increase dosage per healthcare provider’s instructions

• Use Saxenda pens with NovoFine® needles (sold separately)

Saxenda 0.6mg Injection Pen Saxenda Side Effects:

Temporary side effects may include nausea, fatigue, or constipation as your body adapts. Always follow your doctor’s dosage guidance and review the Saxenda Medication Guide.

Storage Instructions:

• Store in a refrigerator (36°F–46°F / 2°C–8°C)

• After first use, can be stored at room temperature (below 86°F / 30°C) for up to 30 days

• Keep capped when not in use